Upstream Bio named Marie Sanchirico head of Medical Affairs, a move aimed at deepening physician and scientific engagement as it advances programs in severe inf

Upstream Bio named Marie Sanchirico head of Medical Affairs, a move aimed at deepening physician and scientific engagement as it advances programs in severe inflammatory respiratory disease. Shares rose 2.6% to $7.44; Phase 3 starts are planned for early 2027.